• Login
  • Register
Nairametrics
  • Home
  • Exclusives
    • Recapitalization
      • Access Holdings Offer
      • Fidelity Bank Offer
      • GTCO Offer
      • Zenith Bank Offer
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Nairalytics
  • Economy
    • Business News
    • Budget
    • Public Debt
    • Tax
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Public Offer & Right Issues
      • Stock Market News
    • Fixed Income
    • Funds Management
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Market Views
    • Op-Eds
    • Research Analysis
  • Home
  • Exclusives
    • Recapitalization
      • Access Holdings Offer
      • Fidelity Bank Offer
      • GTCO Offer
      • Zenith Bank Offer
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Nairalytics
  • Economy
    • Business News
    • Budget
    • Public Debt
    • Tax
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Public Offer & Right Issues
      • Stock Market News
    • Fixed Income
    • Funds Management
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Market Views
    • Op-Eds
    • Research Analysis
Nairametrics
Home Sectors Health

NAFDAC raises alarm on falsified and unregistered oxytocin injections in Nigeria  

Chioma Chukwunedu by Chioma Chukwunedu
February 4, 2024
in Health, Sectors
NAFDAC
Share on FacebookShare on TwitterShare on Linkedin

The National Agency for Food and Drugs Administration and Control (NAFDAC) has issued a public alert regarding the sale of falsified and unregistered brands of Oxytocin Injection in Nigeria.  

These counterfeit products came to light during the Risk-Based Post-Marketing Surveillance (RBPMS) activities conducted by the Post-Marketing Surveillance Directorate of NAFDAC. 

Upon initial physical screening, the products were found to be in gross violation of labelling requirements. The approved recommended storage temperature for Oxytocin Injection is between 2℃ to 8℃.  

MoreStories

Jos DisCo introduces flexible electricity debt repayment plan for customers

Jos DisCo introduces flexible electricity debt repayment plan for customers

March 9, 2026
NSDC, BOI establish N10bn sugar project acceleration fund for greenfield projects

NSDC, BOI establish N10bn sugar project acceleration fund for greenfield projects

March 9, 2026

However, the discovered products stated a storage temperature of below 25℃, indicating a significant deviation from the approved conditions. 

The falsified product details 

What you should know 

  • Oxytocin injection is an essential drug used for inducing labour, controlling bleeding after childbirth, and treating incomplete or inevitable abortion. 
  • The illegal sale of unregistered or falsified medicines poses a substantial risk to public health.  
  • Failing to adhere to the recommended storage temperature compromises the safety, quality, and efficacy of the products.  
  • Administering falsified or unregistered oxytocin injections may cause harm to patients, leading to severe consequences, including death. 

These counterfeit products have been distributed across various parts of the country through both legal and illegal channels. NAFDAC is taking swift action to detect and remove these products from circulation to prevent harm to patients. Consequently, the agency has instructed all State offices to conduct surveillance and recall all batches of these violating products. 

NAFDAC urges importers, distributors, retailers, and healthcare providers to exercise caution and vigilance in the supply chain. All medicinal products should be obtained from authorized and licensed suppliers, with a thorough check of authenticity and physical condition. 

Members of the public possessing the mentioned counterfeit products are advised to discontinue their sale or use and submit the stock to the nearest NAFDAC office. 

If you come across these falsified or unregistered products, it is crucial not to use them. In case of any adverse reactions or events after using the product, immediate medical advice from a qualified healthcare professional is recommended. 


Add Nairametrics on Google News
Follow us for Breaking News and Market Intelligence.
Tags: NAFDAC
Chioma Chukwunedu

Chioma Chukwunedu

Chioma Chukwunedu is a pharmacist and health analyst. She uses data and articles to educate the public about healthcare services and systems so they can make informed decisions about their health.

Next Post
Festus Keyamo,

FX backlog: Banks, not CBN, owe airlines remaining $600 million – Keyamo 

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

rabafast
rabafast

nairametrics





DUNS

Follow us on social media:

  • HOME
  • ABOUT NAIRAMETRICS
  • CONTACT US
  • DISCLAIMER
  • ADs DISCLAIMER
  • COPYRIGHT INFRINGEMENT

© 2026 Nairametrics

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Social Media Auto Publish Powered By : XYZScripts.com
No Result
View All Result
  • Home
  • Exclusives
    • Recapitalization
      • Access Holdings Offer
      • Fidelity Bank Offer
      • GTCO Offer
      • Zenith Bank Offer
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Nairalytics
  • Economy
    • Business News
    • Budget
    • Public Debt
    • Tax
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Public Offer & Right Issues
      • Stock Market News
    • Fixed Income
    • Funds Management
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Market Views
    • Op-Eds
    • Research Analysis
  • Login
  • Sign Up

© 2026 Nairametrics